Harald Schmaderer et al.
FULL PAPERS
7.00 Hz, 2H, N-CH2), 7.41 (s, 1H, Ar-H), 8.07 (s, 1H, Ar-
H); 13C NMR: not measured due to low solubility; 19F NMR
(75 MHz, CDCl3): d=À126.6 (m, 4 F, 2ꢄCF2), À124.0 (m, 2
F, CF2), À123.5 (m, 2 F, CF2), À123.2 (m, 4 F, 2ꢄCF2),
À122.3 to À122.1 (m, 12 F, 6ꢄCF2), À114.8 (tr, J=12.9 Hz,
2 F, CH2CF2), À113.9 (tr, J=13.5 Hz, 2 F, CH2CF2), À81.3
to À81.2 (m, 6 F, CF3); ES-MS: m/z (%)=1135.2 (MH+,
100); HR-MS-EI: m/z=1134.0722, [M]+C, calcd. for
C32H16F34N4O2: 1134.0730 [delta 0.73 ppm].
2ꢄCF2), À122.2 (m, 2 F, CF2), À114.8 (quin, J=16.6 Hz, 2 F,
CH2CF2), À81.2 (tr, J=10.1 Hz, 3 F, CF3); ES-MS: m/z
(%)=747.3 (MH+, 100), 769.3 (MNa+, 16); HR-MS-EI:
m/z=746.1178 [M]+C, calcd. for C25H19F17N4O3: 746.1186
[delta 1.03 ppm].
3-Methylriboflavin Tetraacetate (11)[16,26]
Riboflavin tetraacetate 10 (1.63 g, 3.0 mmol) was dissolved
in dry dimethylformamide (20 mL) and subsequently, caesi-
um carbonate (1.47 g, 4.50 mmol) and methyl iodide
(1.8 mL, 29.0 mmol) were added. After stirring for 16 h at
room temperature in the dark, water (5 mL) was added and
the solvents were evaporated. The crude product was dis-
solved in chloroform (250 mL) and washed with water (2ꢄ
100 mL) and brine. The organic phase was dried over mag-
nesium sulfate and the solvents were evaporated. Purifica-
tion was done by flash column chromatography (Rf =0.15;
chloroform:methanol, 50:1); yield: 1.19 g (2.13 mmol, 71%);
orange solid; mp 1838C; IR (ATR): n=2920, 1737, 1709,
10-Methoxyethyl-3-methylflavin (8a)[16]
Flavin 7 (306 mg, 1.02 mmol) was dissolved in dry dimethyl-
formamide (40 mL) and subsequently, caesium carbonate
(488 mg, 1.50 mmol) and methyl iodide (1.37 g, 9.64 mmol)
were added and the mixture was stirred for 18 h at room
temperature in the dark. The suspension was diluted with
chloroform and washed with water (3ꢄ100 mL) and brine.
The organic phase was dried over magnesium sulfate and
the solvents were evaporated. The crude product was puri-
fied by flash column chromatography (Rf =0.2; chloroform:-
methanol, 100:1); yield: 293 mg (930 mmol, 91%); yellow
solid; mp 2558C (decomp.). IR (ATR): n=2921, 1703, 1651,
1659, 1532, 1373, 1209, 1034 cmÀ1
;
1H NMR (300 MHz,
CDCl3): d=1.70 (s, 3H, Ac-CH3), 2.05 (s, 3H, Ac-CH3),
2.20 (s, 3H, Ac-CH3), 2.27 (s, 3H, Ac-CH3), 2.40 (s, 3H, Ar-
CH3), 2.52 (s, 3H, Ar-CH3), 3.45 (s, 3H, N-CH3), 4.22 (dd,
J=12.35 Hz, J=5.76 Hz, 1H, CH), 4.40 (dd, J=12.21 Hz,
J=2.61 Hz, 1H, CH), 4.59–5.26 (m, 2H, CH), 5.35–5.45 (m,
2H, CH), 5.62–5.65 (m, 1H, CH), 7.51 (s, 1H, Ar-H), 7.97
(s, 1H, Ar-H); 13C NMR (75 MHz, CDCl3): d=19.5 (Ar-
CH3), 20.4 (Ac-CH3), 20.8 (Ac-CH3), 20.9 (Ac-CH3), 21.1
(Ac-CH3), 21.5 (Ar-CH3), 28.7 (N-CH3), 44.6 (CH2), 61.9
(CH2), 69.0 (CH), 69.4 (CH), 70.4 (CH), 115.4 (C-9), 131.2
(C-9a), 132.9 (C-6), 134.7 (C-5a), 135.6 (C-4a), 136.7 (C-7),
147.6 (C-8), 149.1 (C-10a), 155.3 (C-2), 160.0 (C-4), 169.7
(CO), 169.9 (CO), 170.4 (CO), 170.7 (CO); ES-MS: m/z
(%)=559.2 (MH+, 100); HR-MS-EI: m/z=558.1962 [M]+C,
calcd. for C26H30N4O10: 558.1962 [delta À0.01 ppm].
1582, 1540,1451, 1231, 1110, 1014, 970 cmÀ1
;
1H NMR
(300 MHz, CDCl3): d=2.41 (s, 3H, Ar-CH3), 2.51 (s, 3H,
Ar-CH3), 3.26 (s, 3H, O-CH3), 3.49 (s, 3H, N-CH3), 3.88 (tr,
J=5.21 Hz, 2H, O-CH2), 4.87 (tr, J=5.08 Hz, 2H, N-CH2),
7.62 (s, 1H, Ar-H), 7.99 (s, 1H, Ar-H); 13C NMR (75 MHz,
CDCl3): d=19.6 (Ar-CH3), 21.6 (Ar-CH3), 45.4 (N-CH2),
59.3 (O-CH3), 69.6 (O-CH2), 116.7 (C-9), 132.2 (C-9a), 132.3
(C-6), 135.0 (C-5a), 135.5 (C-4a), 136.7 (C-7), 147.6 (C-8),
148.7 (C-10a), 156.0 (C-2), 160.2 (C-4); ES-MS: m/z (%)=
315.0 (MH+, 100); HR-MS-EI: m/z=314.1374 [M]+C, calcd.
for C16H18N4O3: 314.1379 [delta 1.56 ppm].
3-(1H,1H,2H,2H-Perfluorodecyl)-10-methoxyethyl-
flavin (8b)
Flavin 7 (109 mg, 363 mmol) was dissolved in dry dimethyl-
formamide (15 mL) and potassium carbonate (251 mg,
1.81 mmol) was added. After stirring for 20 min, fluorinated
iodide 5 (625 mg, 1.09 mmol) in dry dimethylformamide
(5 mL) was added. After one day, another portion of iodide
5 (417 mg, 726 mmol) was added and the mixture was stirred
for three days at room temperature in the dark. The mixture
was diluted with chloroform and washed with water (3ꢄ
100 mL) and brine (100 mL). The organic phase was dried
over magnesium sulfate and the solvents were evaporated.
The crude brown solid was purified by flash column chroma-
tography (Rf =0.2; chloroform:methanol, 20:1); yield: 63 mg
(84 mmol, 23%); yellow solid; mp 1758C; IR (ATR): n=
2952, 1708, 1663, 1585, 1552, 1197, 1144, 1111, 1003, 958,
3-Methylriboflavin (12)[16,27]
3-Methylriboflavin tetraacetate 11 (280 mg, 501 mmol) was
dissolved in ethanol (50 mL) and p-toluenesulfonic acid
(98 mg, 569 mmol) was added. After refluxing for 17 h, an-
other portion of p-toluenesulfonic acid (49 mg, 285 mmol)
was added and the mixture was refluxed for 3 h. After cool-
ing to room temperature, the solution was stored in the re-
frigerator overnight and a yellow solid precipitated that was
filtered off and dried; yield: 142 mg (364 mmol, 73%);
yellow solid; mp 2758C (decomp.); IR (ATR): n=3230,
1716, 1617, 1579, 1532, 1235 cmÀ1
;
1H NMR (300 MHz,
DMSO-d6): d=2.38 (s, 3H, Ar-CH3), 2.47 (s, 3H, Ar-CH3),
3.27 (s, 3H, N-CH3), 3.44–3.48 (m, 1H, OH), 3.64 (br s, 3H,
3ꢄOH), 4.23–4.26 (m, 1H, CH), 4.51 (tr, J=5.63 Hz, 1H,
CH), 4.58–4.62 (m, 1H, CH), 4.77 (d, J=5.49 Hz, 1H,
CH),4.88–5.00 (m, 2H, CH), 5.13 (d, J=4.67 Hz, 1H, CH),
7.89 (s, 1H, Ar-H), 7.91 (s, 1H, Ar-H); 13C NMR (75 MHz,
DMSO-d6): d=18.8 (Ar-CH3), 20.8 (Ar-CH3), 28.0 (N-CH3),
47.1 (CH2), 63.4 (CH2), 68.8 (CH), 72.8 (CH), 73.6 (CH),
117.4 (C-9), 130.7 (C-6), 132.0 (C-9a), 134.2 (C-5a), 135.7
(C-4a), 135.9 (C-7), 146.2 (C-8), 149.3 (C-10a), 155.0 (C-2),
159.7 (C-4); ES-MS: m/z (%)=391.0 (MH+, 100); HR-MS-
LSI: m/z= 391.1621 [M + H]+, calcd. for C18H23N4O6:
391.1618 [delta À0.87 ppm].
1
719, 657 cmÀ1. H NMR (300 MHz, CDCl3): d=2.44 (s, 3H,
Ar-CH3), 2.49–2.67 (m, 5H, Ar-CH3 + 3-N-CH2), 3.29 (s,
3H, O-CH3), 3.91 (tr, J=5.08 Hz, 2H, 10-N-CH2), 4.45 (tr,
J=7.55 Hz, 2H, CH2C8F17), 4.89 (tr, J=5.21 Hz, 2H, O-
CH2), 7.67 (s, 1H, Ar-H), 8.03 (s, 1H, Ar-H); 13C NMR
(75 MHz, CDCl3): d=19.6 (Ar-CH3), 21.7 (Ar-CH3), 29.8
(CH2C8F17), 34.3 (N-CH2), 45.6 (N-CH2), 59.4 (O-CH3), 69.6
(O-CH2), 116.8 (C-9), 132.4 (C-9a, C-6, C-5a), 135.3 (C-4a),
137.0 (C-7), 148.1 (C-8), 148.9 (C-10a), 155.1 (C-2), 159.9
(C-4); 19F NMR (75 MHz, CDCl3): d=À126.6 (m, 2 F, CF2),
À124.0 (m, 2 F, CF2), À123.2 (m, 2 F, CF2), À122.4 (m, 4 F,
172
ꢁ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 163 – 174